-
2
-
-
33846826849
-
Evaluation, validation and implementation of new microbiological testing methods: PDA Technical Report No. 33
-
PDA
-
PDA. Evaluation, validation and implementation of new microbiological testing methods: PDA Technical Report No. 33. PDA Journal of Pharmaceutical Science and Technology 2000; 54(Suppl. TR33).
-
(2000)
PDA Journal of Pharmaceutical Science and Technology
, vol.54
, Issue.SUPPL. TR33
-
-
-
3
-
-
1542273174
-
Validation of Analytical Procedures. Q2A
-
ICH
-
ICH. Validation of Analytical Procedures. Q2A. Federal Register 1995; 60.
-
(1995)
Federal Register
, pp. 60
-
-
-
4
-
-
33544461571
-
Validation of Analytical Procedures: Methodology. Q2B
-
ICH
-
ICH. Validation of Analytical Procedures: methodology. Q2B. Federal Register 1996; 62.
-
(1996)
Federal Register
, pp. 62
-
-
-
5
-
-
33846805597
-
-
United States Pharmacopoeia. USP 28 〈1225〉. Validation of Compendial Methods.
-
United States Pharmacopoeia. USP 28 〈1225〉. Validation of Compendial Methods.
-
-
-
-
6
-
-
9644304834
-
Development and validation of analytical methods for biopharmaceuticals, part I: Development and optimization
-
Krause SO. Development and validation of analytical methods for biopharmaceuticals, part I: development and optimization. BioPharm International 2004; 17(10):52-61.
-
(2004)
BioPharm International
, vol.17
, Issue.10
, pp. 52-61
-
-
Krause, S.O.1
-
7
-
-
9644262318
-
Development and validation of analytical methods for biopharmaceuticals, part II: Formal validation
-
Krause SO. Development and validation of analytical methods for biopharmaceuticals, part II: formal validation. BioPharm International 2004; 17(11):46-52.
-
(2004)
BioPharm International
, vol.17
, Issue.11
, pp. 46-52
-
-
Krause, S.O.1
-
8
-
-
84940930727
-
Guidance for Industry
-
CDER, Bethesda MD: FDA;
-
CDER. Guidance for Industry. Bioanalytical Method Validation. Bethesda MD: FDA; 2001.
-
(2001)
Bioanalytical Method Validation
-
-
-
9
-
-
33846805596
-
Draft Guidance for Industry
-
CBER, Bethesda MD: FDA;
-
CBER. Draft Guidance for Industry. Analytical Procedures and Methods Validation. Bethesda MD: FDA; 2000.
-
(2000)
Analytical Procedures and Methods Validation
-
-
-
10
-
-
47149089612
-
What is test method qualification? Proceedings of the WCBP CMC strategy forum, 24 July 2003
-
32-47
-
Ritter N., et al. What is test method qualification? Proceedings of the WCBP CMC strategy forum, 24 July 2003. BioProcess International 2004; 2(8):32-47.
-
(2004)
BioProcess International
, vol.2
, Issue.8
-
-
Ritter, N.1
-
11
-
-
9644263210
-
Good analytical method validation practice, part I: Setting-up for compliance and efficiency
-
Krause SO. Good analytical method validation practice, part I: setting-up for compliance and efficiency. Journal of Validation Technology 2002; (9):23-32.
-
(2002)
Journal of Validation Technology
, vol.9
, pp. 23-32
-
-
Krause, S.O.1
-
12
-
-
1542303311
-
Good analytical method validation practice, part II: Deriving acceptance criteria for the AMV protocol
-
Krause SO. Good analytical method validation practice, part II: deriving acceptance criteria for the AMV protocol. Journal of Validation Technology 2003; (9):162-78.
-
(2003)
Journal of Validation Technology
, vol.9
, pp. 162-178
-
-
Krause, S.O.1
-
13
-
-
1542333324
-
Good analytical method validation practice, part III: Data analysis and the AMV report
-
Krause SO. Good analytical method validation practice, part III: data analysis and the AMV report. Journal of Validation Technology 2003; (10):21-36.
-
(2003)
Journal of Validation Technology
, vol.10
, pp. 21-36
-
-
Krause, S.O.1
-
14
-
-
33846782802
-
Analytical method validation
-
Presented at, Feb 25-28; Philadelphia, PA
-
Krause SO. Analytical method validation. Presented at IVT's 10th Annual Meeting; 2004 Feb 25-28; Philadelphia, PA.
-
(2004)
IVT's 10th Annual Meeting
-
-
Krause, S.O.1
|